AIMCA
TRVI icon

Alberta Investment Management Corp (AIMCo)’s Trevi Therapeutics TRVI Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-25,000
Closed -$56K – 1012
2021
Q2 		$56K Buy
+25,000
New +$56.3K ﹤0.01% 942

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
WealthTrust Axiom Wayne, Pennsylvania $406M AUM 40.44% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s TRVI Position: Q3 2021 in Review

Alberta Investment Management Corp (AIMCo) sold out of Trevi Therapeutics (TRVI) in Q3 2021, closing a stake of 25,000 shares — an estimated $56K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in TRVI in Q2 2021 and held it in 1 quarter. The position peaked at $56K in Q2 2021. 18 funds tracked by Wall St. Rank hold TRVI as of Q3 2021.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Trevi Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 25,000 Trevi Therapeutics shares in Q3 2021, an estimated $56K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Trevi Therapeutics in Q2 2021 and held it in 1 quarter.
  • Alberta Investment Management Corp (AIMCo)'s Trevi Therapeutics position peaked at $56K in Q2 2021.
  • 18 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q3 2021.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q3 2021, filed 15 Nov 2021.